PCSK9 and atherosclerosis: A recent study in wild-type, APOE−/−, and LDLR−/− mice with or without expression of PCSK9 revealed a direct relationship between PCSK9 and atherosclerosis development, mainly mediated via the LDLR, and suggests that PCSK9 inhibition will be beneficial in reducing atherosclerosis (11).